Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 329,666 | 191,859 | 176,810 | 291,388 | 143,286 |
| Marketable Securities | 64,130 | 124,260 | 144,266 | 55,013 | 104,636 |
| Receivables | 756 | 798 | 13,604 | 13,267 | 143,071 |
| TOTAL | $400,008 | $324,013 | $340,305 | $366,566 | $400,066 |
| Non-Current Assets | |||||
| PPE Net | 7,172 | 6,950 | 7,190 | 7,461 | 7,393 |
| Intangibles | 2,079 | 2,116 | 2,152 | 2,189 | 2,225 |
| Other Non-Current Assets | 24,899 | 25,584 | 25,535 | 26,263 | 26,978 |
| TOTAL | $34,150 | $34,650 | $34,877 | $35,913 | $36,596 |
| Total Assets | $434,158 | $358,663 | $375,182 | $402,479 | $436,662 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,582 | 2,996 | 3,643 | 4,927 | 3,782 |
| Accrued Expenses | 18,831 | 23,059 | 23,945 | 21,147 | 28,353 |
| TOTAL | $98,049 | $100,924 | $102,033 | $98,785 | $106,001 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 76,636 | 74,869 | 74,445 | 72,711 | 73,866 |
| Other Non-Current Liabilities | 20,807 | 21,675 | 0 | 23,323 | 24,105 |
| TOTAL | $190,087 | $207,936 | $225,085 | $244,865 | $260,894 |
| Total Liabilities | $288,136 | $308,860 | $327,118 | $343,650 | $366,895 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,011 | 64,784 | 46,224 | 46,192 | 45,923 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -465,669 | -450,115 | -435,414 | -420,704 | -405,025 |
| Other shareholders' equity | -43 | -47 | -47 | 16 | 336 |
| TOTAL | $146,022 | $49,803 | $48,064 | $58,829 | $69,767 |
| Total Liabilities And Equity | $434,158 | $358,663 | $375,182 | $402,479 | $436,662 |